Finance

Lists
60Q:FRA
Captor Therapeutics SA
€15.98
-0.13%
(-0.020) 1D
Sep 29, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 60Q...
Open
€16.12
High
€16.12
Low
€15.96
Mkt. cap
444.74M
Avg. vol.
0.00
Volume
0.00
52-wk high
€20.70
52-wk low
€8.88
No. of employees
82
Open
€16.12
High
€16.12
Low
€15.96
Mkt. cap
444.74M
Avg. vol.
0.00
Volume
0.00
52-wk high
€20.70
52-wk low
€8.88
No. of employees
82
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.01M
-
44.00K
328.00K
Cost of goods sold
2.59M
-2.02M
-
-
Cost of revenue
2.59M
-2.02M
-
-
Research and development expenses
10.19M
14.74M
9.82M
10.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.35M
1.37M
2.53M
1.92M
Operating expense
10.16M
13.83M
10.40M
11.59M
Total operating expenses
12.76M
11.81M
10.40M
11.59M
Operating income
-10.74M
-11.81M
-10.36M
-11.26M
Other non operating income
-
1.00K
-8.00K
-
EBT including unusual items
-9.76M
-11.48M
-10.05M
-11.35M
EBT excluding unusual items
-9.76M
-11.48M
-10.12M
-11.35M
Income tax expense
-
-
-
27.00K
Effective tax rate
-
-
-
-0.24%
Other operating expenses
-4.38M
-2.27M
-1.94M
-893.00K
Net income
-9.76M
-11.48M
-10.05M
-11.38M
Net profit margin
-485.32%
-
-22,831.82%
-3,467.99%
Earnings per share
-
-
-
-
Interest and investment income
847.00K
391.00K
303.00K
39.00K
Interest expense
-36.00K
-61.00K
-75.00K
-67.00K
Net interest expenses
811.00K
330.00K
228.00K
-28.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.43M
-10.81M
-9.53M
-10.36M
Gain or loss from assets sale
682.00K
-682.00K
-
-
AI content may include mistakes. Learn more
Google apps